Skip to main content
Acta Endocrinologica (Bucharest) logoLink to Acta Endocrinologica (Bucharest)
. 2022 Oct-Dec;18(4):474–479. doi: 10.4183/aeb.2022.474

EVALUATION OF DISEASE ACCEPTANCE, DEPRESSION, AND QUALITY OF LIFE IN PEOPLE WITH TYPE 2 DIABETES MELLITUS

B Ozyalcin 1, N Sanlier 1,*
PMCID: PMC10162829  PMID: 37152883

Abstract

Context

Diabetes is a serious public health problem that is increasing worldwide.

Objectives

The aim of this study is to evaluate acceptance of the illness, emotional distress, depression and quality of life in individuals with type 2 diabetes mellitus.

Subjects and Methods

This study was conducted in 145 individuals with type 2 diabetes mellitus, 73 males (50.3%) and 72 females (49.7%), ranging in age from 20 to 65 years old. Research data were collected using the face-to-face interview technique by the researchers. The Acceptance of Illness Scale for the determination of individuals’ acceptance of the illness, Problem Areas in Diabetes Scale for emotional distress, Beck Depression Inventory for depression and Short Form-36 scales for quality of life was used.

Results

The mean score of individuals’ Acceptance of Illness Scale was 30.2±5.62. Compared to women, men had lower emotional distress, depression levels (p<0.05), higher physical, mental quality of life (p<0.001). Correlations among acceptance of illness, emotional distress, depression and quality of life were found to be significant (p<0.05). Also, models of multiple linear regression analysis were statistically significant (p=0.000).

Conclusions

The main goal in the treatment of diabetes should be to eliminate complaints in patients, to reduce, prevent or delay the development of complications, to increase the quality of life, to ensure that the individual has a physically, emotionally, spiritually and mentally regular life in addition to metabolic control. For this reason, it is beneficial to carry out the treatment with a multidisciplinary approach in type 2 diabetes mellitus.

Keywords: acceptance of illness, depression, emotional distress, quality of life, type 2 diabetes mellitus

INTRODUCTION

Type 2 diabetes mellitus (T2DM), which is the most common type of DM, accounts for approximately 90-95% of all diabetes cases (1). According to the recent estimations of The International Diabetes Federation, in 2019, 1 (463 million) in every 11 adults (20-79 years old) has diabetes, and this number is predicted to be 700 million in 2045 (2).

Lower levels of patient acceptance of diabetes were significantly associated with less active coping with the disease, reduced self-care, higher glycated hemoglobin (HbA1c) levels, more diabetes distress, and more depressive symptoms. Thus, assessment of diabetes acceptance may facilitate the identification of patients at high risk and may provide a key target for treatments to improve diabetes control (3). Individuals with type 2 diabetes often also experience depression and diabetes distress (4). It is known that high diabetes distress is directly related to decreased self-care and increased HbA1c (5).

Factors affecting quality of life in individuals with DM can be divided into four groups; disease, diet and lifestyle, treatment-related and psychological factors (6). Some complications and accompanying diseases may worsen the quality of life in individuals with T2DM (7). Diabetes distress, many medical factors and sociodemographic factors can also affect quality of life (8, 9). Therefore, the aim of this study is to assess the acceptance of illness, emotional distress, depression and quality of life in individuals with T2DM. The relationship of these factors with each other was also examined.

SUBJECTS AND METHODS

Participants

This study carried out with 145 T2DM volunteer individuals, 73 males and 72 females, aged between 20-65 years, who applied to Family Health Centers between December 2019-June 2020. Individuals that are pregnant, lactating women, have T1DM, newly diagnosed with a disease and using drugs for psychological problems excluded from the study. Written and verbal informed consent was obtained from all individual participants included in the study. In order to carry out this research, ethics committee approval was obtained from the Istanbul Medipol University Non-Interventional Clinical Research Ethics Committee with approval number 1005.

Study plan

The questionary form prepared by researchers, consist of questions examining individuals’ demographic characteristics and health informations. Total of 4 scales were applied. The questionnaire that prepared by researchers was completed while using face-to-face interview technique to the individuals with T2DM.

Materials

Acceptance of Illness Scale (AIS) was generated by Felton and Revenson (10). The scale has 5-point Likert type and consists of 8 items. The total collected point changes between 8-40. Low scores indicate the lack of acceptance of the illness and high score indicate presence of acceptance of the illness. The Cronbach’s α value of the scale is 0.83 (10), and it was found 0.70 in this study. The Problem Areas in Diabetes (PAID) Scale is designed to reduce the spread of emotional responses to DM and to provide taking clinical and research screening measures in DM. The PAID Scale consists of 20 items (11). The scores obtained from the scale are added up, multiplied by 1.25 and converted into 0-100 points. High scores in the scale indicate emotional distress (12). The Cronbach’s α value of the scale is 0.95 (11), and it was found 0.87 in this study. Beck Depression Inventory (BDI) was developed by Beck et al. (13) to determine the level of depression. The scale consists of 21 items and has a 4-point Likert type (14). In this study, Cronbach’s α value was found 0.84. Short Form-36 (SF-36) is one of the most widely used general health measures in quality of life studies with proven validity and reliability (15). Designed by Ware and Sherbourne (16) the SF-36 is a 36-item scale that evaluates eight health concepts. The scale gives a separate total score for each subcomponent, and the subcomponents evaluate health between 0-100. It indicates poor health status as 0 and good health status as 100, and it is understood that the quality of life is good as the score increases. Also, SF-36 can be evaluated as physical component summary (PCS) and as mental component summary (MCS) (17).

Statistical analysis

Statistical Package for Social Sciences (SPSS) version 18 was used to evaluate the data obtained from the study. Continuous variables (quantitative variables) obtained by measurement are presented with mean, standard deviation, minimum and maximum values, and categorical variables (qualitative variables) with frequency and percentage values. Categorical variables were evaluated using the Chi-Square (X2) test. The compliance of the quantitative variables dealt with in the study to normal distribution was examined using the Kolmogorov-Smirnov test. Independent samples t-test were used for the comparison of two independent groups for the variables for which parametric test conditions were met, and the Mann-Whitney U-test was used for the comparison of two independent groups in cases where parametric test conditions were not met. Correlations between variables were analyzed using Spearman correlation coefficient. Multiple linear regression analysis was used for testing multivariate association between variables. In all statistical analyses, p<0.05 value was accepted as the statistical significance level.

RESULTS

This study was conducted on a total of 145 individuals with T2DM between the ages of 20-65, 73 males and 72 females. 93.8% of the individuals were between 46 and 65 years old (Table 1).

Table 1.

Socio-demographic characteristics of individuals

Male (n=73) Female (n=72) Total (n=145)
n % n % n %
Age (years)
20-45 4 5.5 5 7.0 9 6.2
46-65 69 94.5 67 93.0 136 93.8
Educational status
Illiterate - - 6 8.3 6 4.1
Primary and secondary education graduate 29 39.7 48 66.7 77 53.1
High-school graduate 24 32.9 12 16.7 36 24.8
University graduate 20 27.4 6 8.3 26 18.0
Employement status
Working 21 28.8 4 5.5 25 17.2
Not working 52 71.2 68 94.5 120 82.8
Marital status
Single 1 1.4 12 16.6 13 9.0
Married 72 98.6 60 83.4 132 91.0
Individual/s that is/are lived together
Alone - - 3 4.2 3 2.1
Family 73 100.0 69 95.8 142 97.9

The average score of the individuals in AIS was 30.2±5.62. Emotional distress of men (24.2±14.80) was found lower compared to women (32.4±16.83) (p<0.05). The BDI mean score of individuals was 10.1±6.94, 8.7±7.14 for men and 11.6±6.44 for women. The depression level of men was found lower than women (p<0.001). Male individuals’ physical and mental quality of life was found higher than female individual’s (p<0.001) (Table 2).

Table 2.

Acceptance of Illness Scale, Problem Areas in Diabetes Scale, Beck Depression Inventory and Short Form-36 mean score, standard deviation and min-max values of individuals according to gender

Gender MWU/t
p
Male (n=73) Female (n=72) Total (n=145)
±S
(Min-Max)
±S
(Min-Max)
±S
(Min-Max)
AIS 30.8±5.98
(16.0-40.0)
30.8±5.98
(17.0-38.0)
30.2±5.62
(16.0-40.0)
2185.00
0.079MWU
PAID Scale 24.2±14.80
(0.0-66.2)
32.4±16.83
(3.7-80.0)
28.3±16.31
(0.0-80.0)
1869.50
0.003MWUb
BDI 8.7±7.14
(0.0-41.0)
11.6±6.44
(0.0-32.0)
10.1±6.94
(0.0-41.0)
1759.50
0.001MWUa
SF-36 MCS 70.8±19.06
(17.8-100.0)
60.7±18.53
(24.5-95.5)
65.8±19.41
(17.8-100.0)
3.244
0.001ta
SF-36 PCS 77.9±19.17
(18.1-100.0)
55.4±19.5
(20.6-92.5)
66.7±22.33
(18.1-100.0)
972.50
0.000MWUa

t Independent samples t-test, MWU Mann Whitney U test, a p<0.001, b p<0.05.

Also, a negative correlation was found between AIS-PAID Scale and between AIS-BDI, a positive correlation was found between SF-36 MCS-AIS and between SF-36 PCS-AIS (p<0.001). While there was a positive correlation between PAID Scale-BDI, a negative correlation was found between SF-36 MCS-PAID Scale and between SF-36 PCS-PAID Scale (p<0.001). A negative correlation was found between SF-36 MCS-BDI, and between SF-36 PCS-BDI (p<0.001) (Table 3).

Table 3.

Correlation analysis between Acceptance of Illness Scale, Problem Areas in Diabetes Scale, Beck Depression Inventory and Short Form-36 scores of individuals

Scales AIS PAID BDI
PAID r -0.544
pa 0.000b
BDI r -0.452 0.580
pa 0.000b 0.000b
SF-36 MCS r 0.503 -0.471 -0.653
pa 0.000b 0.000b 0.000b
SF-36 PCS r 0.412 -0.497 -0.577
pa 0.000b 0.000b 0.000b

a Spearman Correlation, b p<0.001.

The model that emotional distress and SF-36 MCS with acceptance of illness was found to be statistically significant as a result of multiple linear regression analysis (F(2, 142)=58.404, p=0.001). It has been observed that the effect of PAID Scale on the AIS is greater than the effect of PAID Scale on SF-36 MCS. In individuals with T2DM, it was found that acceptance of the disease increased with increasing SF-36 MCS score and decreased with increasing emotional distress. The model that connects the independent variables of AIS, BDI and age (years) with emotional distress was found to be statistically significant (F(3, 141)=53.174, p=0.001). It was found that emotional distress was decreased with the increasing acceptance of illness and age, and it increased with increasing depression in T2DM individuals. The model that connects emotional distress and SF-36 MCS with the depression state was found to be statistically significant (F(2, 142)=82.029, p=0.000). SF-36 MCS effect on BDI was greater. It was found that with the increasing of SF-36 MCS score the depression status decreased, and with the increasing of emotional distress the depression status increased. The model that connects the acceptance of illness and depression state with SF-36 MCS was found to be statistically significant (F(2, 142)=70.937, p=0.001). It has been determined that SF-36 MCS had a greater effect on the BDI. SF-36 MCS score increased as the acceptance of illness status increased, and SF-36 MCS score decreased as depression status increased. The model that connects emotional distress and depression state with the SF-36 PCS was found to be statistically significant (F(2, 142)=42.926, p=0.000). It was found that BDI had a greater effect on the SF-36 PCS, and as the emotional distress and depression level increased, the SF-36 PCS score decreased in T2DM individuals (Table 4).

Table 4.

Multiple linear regression analysis of Acceptance of Illness Scale, Problem Areas in Diabetes Scale, Beck Depression Inventory and Short Form-36 and various independent variables

Scales Regression Coefficient Standardized Regression Coefficient t p R2
AIS
Constant 28.179 15.094 0.000a 0.444
PAID -0.152 -0.441 -6.124 0.000a
SF-36 MCS 0.096 0.330 4.581 0.000a
PAID
Constant 86.843 7.869 0.000a 0.521
AIS -1.186 -0.409 -6.058 0.000a
BDI 0.769 0.328 4.701 0.000a
Age -0.534 -0.228 -3.793 0.000a
BDI
Constant 17.141 8.090 0.000a 0.530
PAID 0.153 0.359 5.421 0.000a
SF-36 MCS -0.172 -0.481 -7.265 0.000a
SF-36 MCS
Constant 50.608 5.953 0.000a 0.493
AIS 0.987 0.286 4.119 0.000a
BDI -1.439 -0.515 -7.409 0.000a
SF-36 PCS
Constant 90.734 29.665 0.000a 0.368
PAID -0.382 -0.279 -3.359 0.001a
BDI -1.299 -0.404 -4.863 0.000a

R2 Corrected Detarmination Coefficient, t t test, a p<0.001.

DISCUSSION

T2DM is a disease that requires individuals to adhere to a healthy diet, physical activity, and daily medication use and can bring an emotional burden (18). The fact that DM is a chronic disease and brings with it complications weakens the motivation of patients to cope with the disease and their acceptance of the illness (19). Especially, patients with T2DM who are diagnosed later, experience difficulties both mentally and physically while trying to establish a new order for their lives. Anxiety, depression, stress and diabetes distress weaken the motivation of individuals with T2DM to cope with the disease (20). Studies have shown that individuals with T2DM have a low degree of acceptance of the illness (21, 22). However, AIS score may not differ between men and women (21). Similarly, in this study, there was no statistically significant difference between the genders in the acceptance of the illness (p>0.05). However, it is very important for individuals to accept their illnesses in order to show appropriate healthy behaviors.

Emotional distress is observed in most people with T2DM. In a study, the prevalence of diabetes distress in individuals with T2DM was found to be 49.2% (23). In another study, in individuals with early onset (20-45 years old) T2DM, the mean PAID Scale score was found to be higher in women (31.5±21.4) compared to men (21.5±17.4) (24). Similarly in this study, the PAID Scale mean scores of women were higher than men (p<0.05). It is thought that this case is resulted from that women are more sensitive about their own and their families’ health issues, and they have more emotional distress. Depressive symptoms are observed with a higher rate in individuals with T2DM compared to individuals without DM (25-27). In conducted studies, depressive symptoms in patients with DM were observed more frequently in women compared to men (25, 27). Similarly in this study, the BDI mean scores were found to be significantly higher in women compared to men (p<0.05). It is known that there is a two-way causal relationship between depression and DM. The development of anxiety/depression negatively affects the patient’s compliance, response to treatment and the prognosis of the disease. It causes deterioration in self-care and quality of life, an increase in the risk of developing complications, morbidity, mortality and health expenditures, as well. It is thought that traditional gender roles and expectations reveal the psychological consequences like causing despair, so women are more prone to depressive reactions than men. It has been shown that the presence of depression negatively affects the compliance of these patients to treatment (9, 28). Also, it was stated in a study that being a woman and having poor sleep quality increase the possiblity of occurrence of hypoglycemic/hyperglycemic acute events, and anxiety/depression symptoms (29). Also, the presence of T2DM and depression negatively affect the quality of life for individuals (21). It is noteworthy that female individuals’ quality of life is lower compared to male individuals (9, 21, 30). In this study, SF-36 MCS and PCS scores of women were found to be lower than scores of men, as well (p<0.001).

Emotional distress may be experienced during the course of DM, which in return negatively affects the quality of life (31, 32). The quality of life is decreased in individuals with T2DM compared to individuals without diabetes (30). It has been reported that the decrease in the quality of life in individuals with T2DM may result from non-compliance with lifestyle changes (33). The studies have shown that there is a strong negative relationship between depression and quality of life in patients with T2DM (34, 35). In this study, correlations between AIS, PAID Scale, BDI and SF-36 were found to be significant (p<0.05). As a result of the decrease in adherence to medical treatment that occurred according to the decrease in acceptance of illness, problems such as prolongation and delay in the healing process can be seen. For this reason the recommendation of the American Diabetes Association (ADA) is to provide psychosocial care to all individuals with DM in order to improve the health outcomes and quality of life of the individual. It is recommended that all individuals with DM should be evaluated in terms of emotional/diabetes distress, depression and anxiety symptoms (36). Lifestyle behavior change positively affects the general health perception and mental health of individuals (37).

In conclusion, in this study, it was observed that the acceptance of the illness, emotional distress, depression and quality of life of individuals with T2DM could be affected and these may be related to each other. In addition, it has been determined that both mental and physical aspects of the quality of life of individuals with type 2 diabetes can be affected by psychological factors. The main goal in the treatment of diabetes should be to eliminate complaints in patients, to reduce, prevent or delay the development of complications, to increase the quality of life, to ensure that the individual has a physically, emotionally, spiritually and mentally regular life in addition to metabolic control. The strength of this study is that evaluates and compares both male and female individuals with type 2 diabetes in many ways they may have difficulties, thus helping the literature and future studies. The limitations are that more research is needed to generalize the findings.

Conflict of interest

The authors declare that they have no conflict of interest.

References

  • 1.World Health Organization . Geneva: World Health Organization; 2019. Classification of diabetes mellitus. (Accessed January 12, 2020, at site < https://apps.who.int/iris/handle/10665/325182>) [Google Scholar]
  • 2.International Diabetes Federation IDF Diabetes Atlas 9th ed, Brussels, Belgium. 2019. (Accessed February 4, 2020, at site < https://diabetesatlas.org/en/resources/>)
  • 3.Schmitt A, Reimer A, Kulzer B, Haak T, Gahr A, Hermanns N. Assessment of diabetes acceptance can help identify patients with ineffective diabetes self-care and poor diabetes control. Diabet Med. 2014;31(11):1446–1451. doi: 10.1111/dme.12553. [DOI] [PubMed] [Google Scholar]
  • 4.Owens-Gary MD, Zhang X, Jawanda S, Bullard KM, Allweiss P, Smith BD. The importance of addressing depression and diabetes distress in adults with type 2 diabetes. J Gen Intern Med. 2019;34(2):320–324. doi: 10.1007/s11606-018-4705-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Asuzu CC, Walker RJ, Williams JS, Egede LE. Pathways for the relationship between diabetes distress, depression, fatalism and glycemic control in adults with type 2 diabetes. J Diabetes Complications. 2017;31(1):169–174. doi: 10.1016/j.jdiacomp.2016.09.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Khan PA, Nousheen BS, Sultana K, Hyder MH, Umama H. Diabetes Mellitus in Relation to Medication Adherence and Quality of Life. World Health. 2019;17(3):2135–2146. [Google Scholar]
  • 7.Roman G, Teodorescu G. Increased Prevalence of Cardiovascular Risk Factors in Newly Diagnosed Type 2 Diabetes Patients-A Retrospective Study. Acta Endocrinologica-Bucharest. 2021;17(3) doi: 10.4183/aeb.2021.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Tekir O, Cevik C, Kaymak GO, Kaya A. The Effect of Diabetes Symptoms on Quality of Life in Individuals with Type 2 Diabetes. Acta Endocrinologica-Bucharest. 2021;17(2):186–193. doi: 10.4183/aeb.2021.186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Altınok A, Marakoğlu K, Kargın NÇ. Evaluation of quality of life and depression levels in individuals with Type 2 diabetes. J Family Med Prim Care. 2016;5(2):302. doi: 10.4103/2249-4863.192358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Felton BJ, Revenson TA. Coping with chronic illness: A study of illness controllability and the influence of coping strategies on psychological adjustment. J Consult Clin Psychol. 1984;52(3):343–353. doi: 10.1037//0022-006x.52.3.343. [DOI] [PubMed] [Google Scholar]
  • 11.Polonsky WH, Anderson BJ, Lohrer PA, Welch G, Jacobson AM, Aponte JE, Schwartz CE. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754–760. doi: 10.2337/diacare.18.6.754. [DOI] [PubMed] [Google Scholar]
  • 12.Huis In‘T Veld EM, Makine C, Nouwen A, Karşıdağ Ç, Kadıoğlu P, Karşıdağ K, Pouwer F. Validation of the Turkish version of the problem areas in diabetes scale. Cardiovasc Psychiatry Neurol. 2011;2011:1–6. doi: 10.1155/2011/315068. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4(6):561–571. doi: 10.1001/archpsyc.1961.01710120031004. [DOI] [PubMed] [Google Scholar]
  • 14.Beck AT, Steer RA, Brown G. Beck depression inventory–II. Psychol Assess. 1996.
  • 15.Nair R, Kachan P. Outcome tools for diabetes-specific quality of life: study performed in a private family practice clinic. Can Fam Physician. 2017;63(6):e310–e315. [PMC free article] [PubMed] [Google Scholar]
  • 16.Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36) Conceptual framework and item selection. Med Care. 1992;30(6):473–483. [PubMed] [Google Scholar]
  • 17.Ware JE. SF-36 health survey update. Spine (Phila Pa 1976) 2000;25(24):3130–3139. doi: 10.1097/00007632-200012150-00008. [DOI] [PubMed] [Google Scholar]
  • 18.Kasteleyn MJ, de Vries L, Van Puffelen AL, Schellevis FG, Rijken M, Vos RC, Rutten GEHM, Diacourse study group Diabetes-related distress over the course of illness: results from the Diacourse study. Diabet Med. 2015;32(12):1617–1624. doi: 10.1111/dme.12743. [DOI] [PubMed] [Google Scholar]
  • 19.Özkaptan BB, Kapucu S, Demirci İ. Relationship between adherence to treatment and acceptance of illness in patients with type 2 diabetes. Cukurova Medical Journal. 2019;44(1):447–454. [Google Scholar]
  • 20.McCoy MA, Theeke LA. A systematic review of the relationships among psychosocial factors and coping in adults with type 2 diabetes mellitus. Int J Nurs Sci. 2019;6(4):468–477. doi: 10.1016/j.ijnss.2019.09.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rogon I, Kasprzak Z, Szcześniak Ł. Perceived quality of life and acceptance of illness in people with type 2 diabetes mellitus. Prz Menopauzalny. 2017;16(3):79. doi: 10.5114/pm.2017.70583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Bąk E, Marcisz C, Krzemińska S, Dobrzyn-Matusiak D, Foltyn A, Drosdzol-Cop A. Relationships of sexual dysfunction with depression and acceptance of illness in women and men with type 2 diabetes mellitus. Int J Environ Res Public Health. 2017;14(9):1073. doi: 10.3390/ijerph14091073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Chew BH, Vos R, Mohd-Sidik S, Rutten GE. Diabetes-related distress, depression and distress-depression among adults with type 2 diabetes mellitus in Malaysia. PLoS One. 2016;11(3):e0152095. doi: 10.1371/journal.pone.0152095. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Bo A, Pouwer F, Juul L, Nicolaisen SK, Maindal HT. Prevalence and correlates of diabetes distress, perceived stress and depressive symptoms among adults with early-onset Type 2 diabetes: cross-sectional survey results from the Danish DD2 study. Diabet Med. 2020;37(10):1679–1687. doi: 10.1111/dme.14087. [DOI] [PubMed] [Google Scholar]
  • 25.Nicolau J, Simó R, Sanchís P, Ayala L, Fortuny R, Rivera R, Masmiquel L. Prevalence and clinical correlators of undiagnosed significant depressive symptoms among individuals with type 2 diabetes in a Mediterranean population. Exp Clin Endocrinol Diabetes. 2016;124(10):630–636. doi: 10.1055/s-0042-109606. [DOI] [PubMed] [Google Scholar]
  • 26.Mirghani HO, Elbadawi AS. Depression, anxiety, and daytime sleepiness among type 2 diabetic patients and their correlation with the diabetes control: A case-control study. J Taibah Univ Med Sci. 2016;11(4):374–379. [Google Scholar]
  • 27.Bąk E, Marcisz-Dyla E, MŁynarska A, Sternal D, KadŁubowska M, Marcisz C. Prevalence of Depressive Symptoms in Patients with Type 1 and 2 Diabetes Mellitus. Patient Prefer Adherence. 2020;14:443–454. doi: 10.2147/PPA.S237767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Brieler JA, Lustman PJ, Scherrer JF, Salas J, Schneider FD. Antidepressant medication use and glycaemic control in co-morbid type 2 diabetes and depression. Fam Pract. 2016;33(1):30–36. doi: 10.1093/fampra/cmv100. [DOI] [PubMed] [Google Scholar]
  • 29.Sun N, Lou P, Shang Y, Zhang P, Wang J, Chang G, Shi C. Prevalence and determinants of depressive and anxiety symptoms in adults with type 2 diabetes in China: a cross-sectional study. BMJ Open. 2016;6(8):e012540. doi: 10.1136/bmjopen-2016-012540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Lu Y, Wang N, Chen Y, Nie X, Li Q, Han B, Chen Y, Xia F, Cang Z, Lu M, Meng Y, Lu Y. Health-related quality of life in type-2 diabetes patients: a cross-sectional study in East China. BMC Endocr Disord. 2017;17:38. doi: 10.1186/s12902-017-0187-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Koracevic G, Zdravkovic M. What Is Stress Hyperglycemia? A Suggestion for An Improvement of Its Definition. Acta Endocrinologica-Bucharest. 2021;17(4):548–551. doi: 10.4183/aeb.2021.548. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bruno BA, Choi D, Thorpe KE, Catherine HY. Relationship among diabetes distress, decisional conflict, quality of life, and patient perception of chronic illness care in a cohort of patients with type 2 diabetes and other comorbidities. Diabetes Care. 2019;42(7):1170–1177. doi: 10.2337/dc18-1256. [DOI] [PubMed] [Google Scholar]
  • 33.Saleh F, Mumu SJ, Ara F, Hafez MA, Ali L. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study. BMC Public Health. 2014;14:431. doi: 10.1186/1471-2458-14-431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Li H, Ji M, Scott P, Dunbar-Jacob JM. The effect of symptom clusters on quality of life among patients with type 2 diabetes. Diabetes Educ. 2019;45(3):287–294. doi: 10.1177/0145721719837902. [DOI] [PubMed] [Google Scholar]
  • 35.Zhang P, Lou P, Chang G, Chen P, Zhang L, Li T, Qiao C. Combined effects of sleep quality and depression on quality of life in patients with type 2 diabetes. BMC Fam Pract. 2016;17:40. doi: 10.1186/s12875-016-0435-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.American Diabetes Association 5. Lifestyle management: standards of medical care in diabetes-2019. Diabetes Care. 2019;42(Suppl. 1):46–60. doi: 10.2337/dc19-S005. [DOI] [PubMed] [Google Scholar]
  • 37.Günalay S, Taşkıran E, Demir B, Erdem S, Mergen H, Akar H. Tip2 Diyabetes Mellitus Hastalarında Tedavi Yöntemleri, Glisemik Kontrol ve Diyabet Komplikasyonları ile Depresyon ve Anksiyete Riski Arasındaki İlişki. FNG & Bilim Tıp Dergisi. 2016;2(1):16–19. [Google Scholar]

Articles from Acta Endocrinologica (Bucharest) are provided here courtesy of Acta Endocrinologica Foundation

RESOURCES